We therefore aimed to prospectively investigate the relationships between erythrocyte membrane fatty acid concentrations and subsequent breast cancer risk by tumor tissue expression of several immuno-inflammatory markers (CD4, CD8, CD20, CD163, COX-2) and FAS. The gene discussed is CD163; the disease is breast carcinoma.